R&D

Specific Biologics Strengthens Scientific Advisory Board with Appointment of Tirtha Chakraborty, Ph.D. and Mike Nicholson, Ph.D.

Retrieved on: 
Monday, July 24, 2023

Specific Biologics is an early-stage biotechnology company developing its proprietary two-site Dualase® platform gene editors to build a pipeline of treatments for serious genetic diseases.

Key Points: 
  • Specific Biologics is an early-stage biotechnology company developing its proprietary two-site Dualase® platform gene editors to build a pipeline of treatments for serious genetic diseases.
  • TORONTO, July 24, 2023 /PRNewswire/ - Specific Biologics Inc. ("Specific"), a venture-backed, early-stage genome editing company, is pleased to announce it has appointed Tirtha Chakraborty, Ph.D. and Mike Nicholson, Ph.D. to its scientific advisory board (SAB).
  • Chakraborty and Nicholson join the SAB," said Brent Stead, Ph.D., MBA, CEO of Specific "Their expertise will be incredibly valuable as we advance our Dualase® gene editors toward the clinic.
  • "The Specific team is tackling areas of acute medical need where Dualase gene editors would be well differentiated from existing treatments."

Curia expands biologics capabilities with access to Touchlight’s doggybone DNA

Retrieved on: 
Monday, July 24, 2023

ALBANY, N.Y. and HAMPTON, United Kingdom, July 24, 2023 (GLOBE NEWSWIRE) -- Curia, a leading contract research, development and manufacturing organization, and Touchlight, a company pioneering enzymatic DNA production, today announced an agreement which will provide Curia and its clients a streamlined means of access to Touchlight’s doggybone DNA (dbDNA).

Key Points: 
  • ALBANY, N.Y. and HAMPTON, United Kingdom, July 24, 2023 (GLOBE NEWSWIRE) -- Curia, a leading contract research, development and manufacturing organization, and Touchlight, a company pioneering enzymatic DNA production, today announced an agreement which will provide Curia and its clients a streamlined means of access to Touchlight’s doggybone DNA (dbDNA).
  • The arrangement expands Curia’s mRNA manufacturing offerings with an additional differentiated source of DNA raw material that is immediately available to be accessed by Curia customers.
  • “Curia remains committed to strengthening our biologics offerings and end-to-end mRNA manufacturing capabilities,” said Christopher Conway, President of R&D, Curia.
  • Touchlight’s enzymatic DNA is produced with a cell-free enzymatic process that offers unmatched benefits in speed, quality and capacity when compared to traditional plasmid DNA production.

Planview Reports Record Q2 and H1 2023, Continues Momentum Amid Challenging Economic Landscape

Retrieved on: 
Thursday, July 20, 2023

Planview , the leading platform for digital connected work from portfolio planning to delivery, announced today record annual recurring revenue (ARR) and bookings in Q2, continuing strong momentum and growth in 2023.

Key Points: 
  • Planview , the leading platform for digital connected work from portfolio planning to delivery, announced today record annual recurring revenue (ARR) and bookings in Q2, continuing strong momentum and growth in 2023.
  • At the close of H1 2023, Planview is outpacing its forecasts on several key measures, including bookings, retention, and ARR this year.
  • “The macroenvironment continues to pose challenges for digital transformation efforts in companies around the world.
  • Organizations are faced with inflation, changing customer expectations, and more conservative budgets,” said Razat Gaurav, CEO at Planview.

Manhattan Associates Named a Best Workplace for Innovators by Fast Company

Retrieved on: 
Tuesday, July 11, 2023

Manhattan Associates Inc. (NASDAQ: MANH) today announced it has been named one of the “Best Workplaces for Innovators” by Fast Company.

Key Points: 
  • Manhattan Associates Inc. (NASDAQ: MANH) today announced it has been named one of the “Best Workplaces for Innovators” by Fast Company.
  • Now in its fifth year, the list honors organizations that demonstrate an inspiring commitment to encourage and develop innovation at all levels.
  • With approximately 1000 team members in R&D, Manhattan has a legacy and unwavering commitment to supply chain innovation.
  • “We are delighted that Manhattan has been named a ‘Best Workplace for Innovators’ by Fast Company.

ClassOne Equipment Delivers Advanced 300mm Takano Particle Detection System to EUV Tech

Retrieved on: 
Monday, June 5, 2023

ATLANTA, June 5, 2023 /PRNewswire/ -- ClassOne Equipment ( classoneequipment.com ), announced the delivery of its advanced new Takano WM-10 particle measurement system to EUV Tech, a global leader in metrology equipment for cutting-edge EUV chip manufacturing.

Key Points: 
  • ATLANTA, June 5, 2023 /PRNewswire/ -- ClassOne Equipment ( classoneequipment.com ), announced the delivery of its advanced new Takano WM-10 particle measurement system to EUV Tech, a global leader in metrology equipment for cutting-edge EUV chip manufacturing.
  • The announcement was made by ClassOne Equipment Vice President, David Pawlak, and EUV Tech Vice President of R&D, Matt Hettermann.
  • Said Hettermann, "A key factor in our selecting the new 300mm Takano WM-10 system was its very high-sensitivity particle detection.
  • ClassOne Equipment is the exclusive source for sales, service and complete support of Takano-brand particle detection systems across North America and Europe.

ASE VIPack™ FOCoS-Bridge integrates multiple ASICs and silicon bridges to accelerate AI innovation

Retrieved on: 
Wednesday, May 31, 2023

FOCoS-Bridge technology addresses the increasing demand for higher bandwidth and faster data transfer rates in AI and HPC applications.

Key Points: 
  • FOCoS-Bridge technology addresses the increasing demand for higher bandwidth and faster data transfer rates in AI and HPC applications.
  • ASE’s FOCoS-Bridge features ultra-high density D2D interconnection with submicron L/S, enabling high bandwidth at low latency for chiplet integration.
  • The use of a silicon bridge die enables a die edge linear density (wire/mm/layer) that is nearly 200x higher than the traditional organic flip chip package.
  • The convergence of AI and HPC is having a strong impact on the semiconductor industry, fueling demand for innovative packaging solutions.

AVEVA Further Strengthens Executive Leadership Team with Four New Senior Roles

Retrieved on: 
Thursday, May 25, 2023

AVEVA , a global leader in industrial software, has further strengthened its leadership team announcing four new senior executive roles as the company drives forward its new business model.

Key Points: 
  • AVEVA , a global leader in industrial software, has further strengthened its leadership team announcing four new senior executive roles as the company drives forward its new business model.
  • Sue Quense, currently AVEVA’s Senior Vice President of Americas, takes on the newly created role of Chief Commercial Officer.
  • Quense, based in Philadelphia, USA, has spent more than three decades in software sales leadership roles.
  • Sue, Marco, Rob and Iju will be instrumental in further enhancing our leadership team and driving growth.”

World Small-scale Bioreactors Market Analysis Report 2023-2030: Use of Small-scale Bioprocessing Systems in Upstream Processing, Parallel Processing, and Experiment Evaluation Bolsters Demand - ResearchAndMarkets.com

Retrieved on: 
Monday, May 15, 2023

Moreover, the use of small-scale bioprocessing systems in upstream processing, parallel processing, and experiment evaluation for bioprocess optimization is expected to drive the demand for small-scale bioreactors in process development.

Key Points: 
  • Moreover, the use of small-scale bioprocessing systems in upstream processing, parallel processing, and experiment evaluation for bioprocess optimization is expected to drive the demand for small-scale bioreactors in process development.
  • In addition, the demand for bioprocessing technologies had also grown as a result of a rise in vaccine R&D.
  • Furthermore, the growth of the market during the forecast period is fueled by the rise in technical development and advancements in equipment design for bioprocessing.
  • Since these companies have adopted novel single-use bioreactors much more quickly than therapeutic manufacturers, they have contributed to a larger revenue share

iPipeline® Continues Its Commitment to Strategic Growth by Adding Three Key Industry Leaders

Retrieved on: 
Tuesday, May 9, 2023

EXTON, Pa., May 9, 2023 /PRNewswire/ -- iPipeline® announces that it recently added three experienced professionals to its leadership team. These appointments are part of the company's ongoing commitment to creating a fulfilling, inclusive, and productive environment for its team of Pipers—as the firm continues to strategically transform the life insurance and financial services industries through its innovative technology solutions.

Key Points: 
  • He also served as deputy general counsel for the Marine Corps' enterprise level logistics command, and as a headquarters company commander.
  • With an extensive background in all aspects of human resources, Diane Rowell also recently joined iPipeline as the company's Chief People Officer.
  • In addition to Mr. McDonnell and Ms. Rowell, Aaron Guidotti recently joined iPipeline as Vice President of Research & Development.
  • He led Equisoft's global growth strategy following the firm's acquisition of Grendel—which offers a leading customer relationship management built for the wealth management industry—where he served as CEO.

ASE wins Device Technology of the Year award for VIPack™

Retrieved on: 
Tuesday, May 2, 2023

Advanced Semiconductor Engineering, Inc. (ASE), a member of ASE Technology Holding Co., Ltd. (NYSE: ASX, TAIEX: 3711), today announced that its VIPack™ has received the ‘Device Technology of the Year Award’ in the 2023 3D InCites Awards program.

Key Points: 
  • Advanced Semiconductor Engineering, Inc. (ASE), a member of ASE Technology Holding Co., Ltd. (NYSE: ASX, TAIEX: 3711), today announced that its VIPack™ has received the ‘Device Technology of the Year Award’ in the 2023 3D InCites Awards program.
  • View the full release here: https://www.businesswire.com/news/home/20230502005061/en/
    Introduced in 2022, VIPack™ is an advanced packaging platform designed to enable vertically integrated package solutions.
  • VIPack™ represents ASE’s next generation of 3D heterogeneous integration architecture that extends design rules and achieves ultra-high density and performance.
  • ASE’s VIPack™ is comprised of six core packaging technology pillars supported by a comprehensive and integrated co-design ecosystem.